Intended for healthcare professionals

News

New law to control prices of generic drugs

BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2139 (Published 02 May 2017) Cite this as: BMJ 2017;357:j2139
  1. Deborah Cohen
  1. BMJ

The UK parliament has passed new legislation to close a loophole that allowed companies to raise the prices of unbranded generic drugs.

The Health Services Medicinal Supplies (Costs) Act will give the government the power to control the prices of generic drugs if it believed excessive prices were being charged. For unbranded generic drugs, the government had relied on the market to keep prices down.

A recent Organisation for Economic Co-operation and Development report said that average generic drug prices in the UK are the …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription